Literature DB >> 32201993

The relationship between cam morphology and hip and groin symptoms and signs in young male football players.

Pim van Klij1, Abida Z Ginai2, Marinus P Heijboer1, Jan A N Verhaar1, Jan H Waarsing1, Rintje Agricola1.   

Abstract

BACKGROUND: Conflicting and limited high-quality prospective data are available on the associations between cam morphology and hip and groin symptoms and range of motion (ROM).
OBJECTIVES: This cross-sectional cohort study investigated associations between cam morphology presence, size and duration and symptoms and ROM.
METHODS: Academy male football players (n = 49, 17-24 years) were included. Standardized antero-posterior pelvic and frog-leg lateral radiographs were obtained at baseline, 2.5- and 5-year follow-up. The femoral head-neck junction was quantified by: Visual score. Cam morphology (flattening or prominence), large cam (prominence). Alpha angle. Cam morphology (≥60°), large cam (≥78°). Cam morphology duration was defined as long (first present at baseline) or short (only from 2.5- to 5-year follow-up). Current symptoms at 5-year follow-up were assessed using a hip and groin pain question and by the "Hip and Groin Outcome Score" (HAGOS). HAGOS scores were categorized into: most symptoms (≥2 domains in lowest interquartile range [IQR]), least symptoms (≥2 domains in highest IQR). Hip ROM was measured by goniometry at 5-year follow-up.
RESULTS: Large cam morphology based on visual score was associated with hip and groin pain (23.8% vs. 7.1%, OR: 3.17, CI: [1.15-8.70], P = .026), but not with HAGOS scores. Cam morphology presence, size, and duration were associated with limited flexion of around 6° and/or 3° to 6° for internal rotation.
CONCLUSION: Cam morphology presence, size, and duration were associated with limited hip flexion and/or internal rotation, but differences might not exceed the minimal clinical important difference. Whether cam morphology results in symptoms is uncertain.
© 2020 The Authors. Scandinavian Journal of Medicine & Science In Sports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FAI syndrome; femoroacetabular impingement; pain; range of motion

Year:  2020        PMID: 32201993     DOI: 10.1111/sms.13660

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  6 in total

Review 1.  Classifying Cam Morphology by the Alpha Angle: A Systematic Review on Threshold Values.

Authors:  Pim van Klij; Michael P Reiman; Jan H Waarsing; Max Reijman; Wichor M Bramer; Jan A N Verhaar; Rintje Agricola
Journal:  Orthop J Sports Med       Date:  2020-08-10

2.  Hip and Groin Injury Prevention in Elite Athletes and Team Sport - Current Challenges and Opportunities.

Authors:  Steven M Short; Cameron W MacDonald; Donald Strack
Journal:  Int J Sports Phys Ther       Date:  2021-02-01

3.  Less hip range of motion is associated with a greater alpha angle in people with longstanding hip and groin pain.

Authors:  August Estberger; Anders Pålsson; Ioannis Kostogiannis; Eva Ageberg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-09-12       Impact factor: 4.342

Review 4.  Hip Range of Motion Is Increased After Hip Arthroscopy for Femoroacetabular Impingement: A Systematic Review.

Authors:  David Filan; Karen Mullins; Patrick Carton
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-01-22

5.  Are cam morphology size and location associated with self-reported burden in football players with FAI syndrome?

Authors:  Mark J Scholes; Joanne L Kemp; Benjamin F Mentiplay; Joshua J Heerey; Rintje Agricola; Matthew G King; Adam I Semciw; Peter R Lawrenson; Kay M Crossley
Journal:  Scand J Med Sci Sports       Date:  2022-01-24       Impact factor: 4.645

6.  Hip pain and its correlation with cam morphology in young skiers-a minimum of 5 years follow-up.

Authors:  Josefin Abrahamson; Pall Jónasson; Mikael Sansone; Anna Swärd Aminoff; Carl Todd; Jón Karlsson; Adad Baranto
Journal:  J Orthop Surg Res       Date:  2020-09-29       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.